Table 2.
List of oppositely up- or downregulated KEGG pathways in the longissimus dorsi muscle tissue compared to intramuscular, subcutaneous, and omental adipose tissues in Hanwoo.
| KEGG ID | Pathway | Fold enrichment | Bonferroni | |
|---|---|---|---|---|
| Upregulated | bta05012 | Parkinson's disease† | 4.2 | 1.4E − 27 |
| bta05010 | Alzheimer's disease† | 3.7 | 5.3E − 26 | |
| bta00190 | Oxidative phosphorylation† | 4.0 | 8.3E − 26 | |
| bta05016 | Huntington's disease† | 3.4 | 2.2E − 22 | |
| bta03050 | Proteasome† | 5.3 | 9.5E − 15 | |
| bta04260 | Cardiac muscle contraction | 3.7 | 3.2E − 10 | |
| bta00020 | Citrate cycle (TCA cycle)† | 5.1 | 8.7E − 09 | |
| bta05410 | Hypertrophic cardiomyopathy (HCM) | 2.7 | 4.9E − 04 | |
| bta05414 | Dilated cardiomyopathy | 2.5 | 1.9E − 03 | |
| bta00230 | Purine metabolism | 2.0 | 2.8E − 03 | |
| bta04120 | Ubiquitin mediated proteolysis | 2.1 | 3.2E − 03 | |
| bta00620 | Pyruvate metabolism† | 3.0 | 2.7E − 02 | |
| bta00010 | Glycolysis/gluconeogenesis | 2.6 | 2.9E − 02 | |
|
| ||||
| Downregulated | bta04510 | Focal adhesion‡ | 1.9 | 1.3E − 06 |
| bta04512 | ECM-receptor interaction‡ | 2.4 | 5.0E − 06 | |
| bta04640 | Hematopoietic cell lineage | 2.3 | 1.9E − 05 | |
| bta04062 | Chemokine signaling pathway‡ | 1.8 | 4.7E − 05 | |
| bta04360 | Axon guidance‡ | 2.0 | 7.5E − 05 | |
| bta04670 | Leukocyte transendothelial migration | 2.0 | 1.1E − 04 | |
| bta04060 | Cytokine-cytokine receptor interaction | 1.7 | 6.3E − 04 | |
| bta00600 | Sphingolipid metabolism | 2.7 | 3.7E − 03 | |
| bta04514 | Cell adhesion molecules (CAMs) | 1.8 | 4.2E − 03 | |
| bta04810 | Regulation of actin cytoskeleton‡ | 1.6 | 5.9E − 03 | |
| bta04142 | Lysosome | 1.8 | 6.6E − 03 | |
| bta04666 | Fc gamma R-mediated phagocytosis | 2.0 | 8.6E − 03 | |
†Downregulated in the intramuscular adipose tissue.
‡Upregulated in the intramuscular adipose tissue.